Cogensus key facts
as of Oct 2026- Developer of a cognitive health engagement platform designed to support and monitor brain health in older adults.
- Cogensus is valued at approximately $8.0M as of Oct 2026 (last reported valuation).
- It has raised $520K; the latest was Corporate ($250K) in Nov 2025.
- Notable investors include Caduceus Capital Partners.
- Status: Privately Held (backing).
Cogensus's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- ·Watch Cogensus: the Monday email on marks, rounds and moves
Cogensus funding rounds
No funding rounds for Cogensus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Cogensus
1Cogensus valuation
Cogensus's last reported valuation was $8 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.
Cogensus investors
1 investor is on record for Cogensus, including Caduceus Capital Partners. By type, the record holds 1 venture capital firm.
About Cogensus
Developer of a cognitive health engagement platform designed to support and monitor brain health in older adults. The company's platform offers personalized cognitive exercises, social interaction features, progress tracking, remote monitoring capabilities and data analytics, enabling healthcare providers, caregivers and families to proactively address cognitive decline, reduce risks associated with loneliness and improve overall brain health outcomes for the aging population.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2024
- Employees
- 12
- Website
- cogensus.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.